CWBHF · Charlotte's Web Holdings, Inc.
Market Cap
$84.37M
Shares
271.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.31
Open$0.29
Day$0.29–0.31
52W close$0.09–0.92
Avg vol 30d225K
Short int277K · 0.1% float · 1.0d
Short vol26%
Last earningsAug 13, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 13, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−27%
below
Price vs 50-day avg
+8%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
26%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+34%
trailing
6-month return
−57%
trailing
YTD return
−17%
this year
Relative strength
−71%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.10% of float · ▼ -41.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — mid 3-yr range
Squeeze score
22
low risk · 0–100
Fundamentals
Revenue growth
+0%
Y/Y
Gross margin
43%
expanding
EPS growth
0%
Y/Y
Quant / Vol
risk profile
Volatility
150%
annualized · 1-yr
Max drawdown
−77%
past year
ATR
12.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 13, 2026
Gross margin
· target range of approximately 50%
at least 50%
Prior guidance
period ended
· from the 8-K filed Mar 19, 2025
Gross margin
· 2025
at least 50%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−27%
Bearish
Price vs 50-day avg
+8%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
26%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.10% of float · ▼ -41.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 26%
Range high $1
vs 200-day avg -27%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$4.65M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Capital expenditures | 50K | six months ended June 30, 2026 | — |
| EBITDA non-GAAP | -$12.83M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Gross margin | 47.5% | Q2 2026 | — |
| Net cash used in operating activities | $3.7M | six months ended June 30, 2026 | — |
| Operating cash use | $0.9M | Q2 2026 | — |
| Working capital | $21.7M | Fiscal Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CWBHF
this stock
Charlotte's Web Holdings, Inc.
|
$84.37M | -16.8% | +0.5% | — | 0.1% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$57.59B | +15.7% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.41B | +2.2% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.15B | +0.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CWBHF | -8.1% | +34.5% | -57.1% | +34.5% | -16.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -8.5% | +31.5% | -70.5% | +31.5% | -29.7% |